Literature DB >> 2191091

The International Cooperative Study on the Timing of Aneurysm Surgery. Part 2: Surgical results.

N F Kassell1, J C Torner, J A Jane, E C Haley, H P Adams.   

Abstract

A prospective, observational clinical trial was conducted by the International Cooperative Study on the Timing of Aneurysm Surgery to determine the best time in relation to the hemorrhage for surgical treatment of ruptured intracranial aneurysms. Sixty-eight centers contributed 3521 patients in a 2 1/2-year period beginning in December, 1980. Analysis by a prespecified "planned" surgery interval demonstrated that there was no difference in early (0 to 3 days after the bleed) or late surgery (11 to 14 days). Outcome was worse if surgery was performed in the 7 to 10-day post-bleed interval. Surgical results were better for patients operated on after 10 days. Patients alert on admission fared best; however, alert patients had a mortality rate of 10% to 12% when undergoing surgery prior to Day 11 compared with 3% to 5% when surgery was performed after Day 10. Patients drowsy on admission had a 21% to 25% mortality rate when operated on up to Day 11 and 7% to 10% with surgery thereafter. Overall, early surgery was neither more hazardous nor beneficial than delayed surgery. The postoperative risk following early surgery is equivalent to the risk of rebleeding and vasospasm in patients waiting for delayed surgery.

Entities:  

Mesh:

Year:  1990        PMID: 2191091     DOI: 10.3171/jns.1990.73.1.0037

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  140 in total

1.  Lesson of the week: Playing the odds in clinical decision making: lessons from berry aneurysms undetected by magnetic resonance angiography.

Authors:  M R Johnson; C D Good; W D Penny; P R Barnes; J W Scadding
Journal:  BMJ       Date:  2001-06-02

2.  Stent-assisted coil embolization for the proximal middle cerebral artery fusiform aneurysm.

Authors:  Seong-Man Jeong; Shin-Hyuk Kang; Nam-Joon Lee; Dong-Jun Lim
Journal:  J Korean Neurosurg Soc       Date:  2010-05-31

3.  Treatment of subarachnoid hemorrhage with human albumin: ALISAH study. Rationale and design.

Authors:  Jose I Suarez; Renee H Martin
Journal:  Neurocrit Care       Date:  2010-10       Impact factor: 3.210

4.  Subarachnoid Hemorrhage.

Authors:  K D Flemming; R D Brown; D O Wiebers
Journal:  Curr Treat Options Neurol       Date:  1999-05       Impact factor: 3.598

5.  Clipping or coiling of ruptured cerebral aneurysms and shunt-dependent hydrocephalus.

Authors:  Panayiotis Varelas; Ann Helms; Grant Sinson; Marianna Spanaki; Lotfi Hacein-Bey
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

Review 6.  Phenotypic transformation of smooth muscle in vasospasm after aneurysmal subarachnoid hemorrhage.

Authors:  Norihito Shimamura; Hiroki Ohkuma
Journal:  Transl Stroke Res       Date:  2013-11-20       Impact factor: 6.829

Review 7.  Aneurysmal Subarachnoid Hemorrhage.

Authors:  Athanasios K Petridis; Marcel A Kamp; Jan F Cornelius; Thomas Beez; Kerim Beseoglu; Bernd Turowski; Hans-Jakob Steiger
Journal:  Dtsch Arztebl Int       Date:  2017-03-31       Impact factor: 5.594

8.  Thromboembolic events associated with Guglielmi detachable coil embolization of asymptomatic cerebral aneurysms: evaluation of 66 consecutive cases with use of diffusion-weighted MR imaging.

Authors:  Akio Soeda; Nobuyuki Sakai; Hideki Sakai; Koji Iihara; Naoaki Yamada; Satoshi Imakita; Izumi Nagata
Journal:  AJNR Am J Neuroradiol       Date:  2003-01       Impact factor: 3.825

9.  Combined endovascular treatment for both intracranial aneurysm and symptomatic vasospasm.

Authors:  Yuichi Murayama; Joon K Song; Ken Uda; Y Pierre Gobin; Gary R Duckwiler; Satoshi Tateshima; Aman B Patel; Neil A Martin; Fernando Viñuela
Journal:  AJNR Am J Neuroradiol       Date:  2003-01       Impact factor: 3.825

10.  Perimesencephalic and nonperimesencephalic subarachnoid haemorrhages with negative angiograms.

Authors:  P Canhão; J M Ferro; A N Pinto; T P Melo; J G Campos
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.